Allurion Technologies Stock
Medical devices for weight loss
About Allurion Technologies Stock
Allurion Technologies is developing a medical device for weight loss that can be delivered and removed without surgery or endoscopy.
Investors
IDO Investments
Romulus Capital
The Family
Funding History
| July 2012 | $1.7M |
|---|---|
| April 2013 | $2.9M |
| July 2014 | $5.5M |
| July 2017 | $27.3M |
Management
Chief Executive Office
Jonathan Wecker
Co-Founder
Samuel Levy
Co-Founder
Shantanu Gaur
Press
Allurion Technologies Completes Enrollment in Landmark Pivotal U.S. Clinical Trial for the Elipse
businesswire - Jul, 24 2018
Allurion completes enrollment of weight loss device study
wbjournal - Jul, 24 2018
New CEO among leadership changes at Allurion
wbjournal - Jan, 2 2018
Another startup hoping to tackle obesity using a device raises $19M
medcitynews - Feb, 3 2017
Allurion offers gastric bypass surgery in a pill
TechCrunch - May, 17 2016
Allurion wins CE Mark for weight loss balloon
massdevice - Dec, 9 2015
Other Companies
EquityZen does not have an affiliation with, formal relationship with, or endorsement from Allurion Technologies or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
